Genotype characterisation for diagnostics

Microarrays in Diagnostics and Biomarker Development: Current and Future Applications

Volumn , Issue , 2012, Pages 29-38

  Jordan, Bertrand ^a  

^a CoReBio PACA ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS; DNA SEQUENCES; OLIGONUCLEOTIDES; POLYMERASE CHAIN REACTION; VIRUSES;

COPY NUMBER VARIATIONS; DNA ARRAY; GENOTYPING; PCR ASSAY; SIMPLE++; SPECIFIC SEQUENCES;

DNA;

EID: 84878304584     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-28203-4_4     Document Type: Chapter

References (26)

1. Ambry genetics (2010)http://www.ambrygen.com/AmbryScreen-News.html. Accessed 26 July 2011.
2. Bejjani BA, Shaffer LG (2006) Application of array-based comparative genomic hybridization to clinical diagnostics. J Mol Diagn 8:528-553.
3. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE et al (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med. 3:65ra4.
4. Counsyl (2011) http://www.counsyl.com. Accessed 26 July 2011.
5. Daly AK (2003) Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 17:27-41.
6. GeneTest (2010) http://www.ncbi.nlm.nih.gov/sites/GeneTests/Accessed 30 July 2011.
7. GenMarkDx eSensor® Cystic Fibrosis Genotyping Test (2011) http://www.genmarkdx.com/products/reagents/cf.php. Accessed 26 July 2011.
8. Government Accountability Office (2010) Direct-to-consumer genetic tests: Misleading test results are further complicated by deceptive marketing and other questionable practices. GAO-10-847TT.http://www.gao.gov/new.items/d10847t.pdf Accessed 30 July 2011.
9. Jain KK (2005) Applications of AmpliChip CYP450. Mol Diagn 9:119-127.
10. Johnson MA, Yoshitomi MJ, Richards CS (2007) A comparative study of five technologically diverse CFTR testing platforms. J Mol Diagn 9:401-407.
11. Kaback MM (2000) Population-based genetic screening for reproductive counseling: The Tay- Sachs disease model. Eur J Pediatr 159:S192-S195.
12. Katsanis SH, Javitt G, Hudso K (2008) A case study of personalized medicine. Science 320:53-54.
13. Leinonen M, Nieminen P, Kotaniemi-Talonen L et al (2009) Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 101:1612-1623.
14. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA et al (2009) Finding the missing heritability of complex diseases. Nature 461:747-753.
15. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9:356-369.
16. Metzker ML (2010) Sequencing technologies - The next generation. Nat Rev Genet 11:31-46.
17. Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, Gibson RL et al (2008) Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med 10:851-868.
18. National Cancer Institute, Pap test (2010) http://www.cancer.gov/cancertopics/factsheet/Detection/Pap-test Accessed 26 July 2011.
19. Partners Healthcare (2011) http://www.partners.org/.Accessed 31 July 2011.
20. Progenika Biopharma (2011) http://www.progenika.com/eu/Accessed 31 July 2011.
21. Quill E (2008) Blood-matching goes genetic. Science 319:1478-1479.
22. Reich DE, Lander ES (2001) On the allelic spectrum of human disease. Trends Genet 17:502-510.
23. Schrijver I (2011) Mutation distribution in expanded screening for cystic fibrosis: Making up the balance in a context of ethnic diversity. Clin Chem 57:799-801.
24. Srinivasan BS, Evans EA, Flannick J, Patterson AS, Chang CC et al (2010) A universal carrier test for the long tail of Mendelian disease. Reprod Biomed Online 21:537-551.
25. Veltman JA (2006) Genomic microarrays in clinical diagnosis. Curr Opin Pediatr 18:598-603.
26. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K et al (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6:387-391.